The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Lung cancer biomarkers in exhaled breath
Abstract
Lung cancer is the leading cause of cancer-related mortality worldwide. Methods for early detection of lung cancer, such as computerized tomography scanning technology, often discover a large number of small lung nodules, posing a new problem to radiologists and chest physicians. The vast majority of these nodules will be benign, but there is currently no easy way to determine which nodules represent very early lung cancer. Adjuvant testing with PET imaging and nonsurgical biopsies has a low yield for these small indeterminate nodules, carries potential morbidity and is costly. Indeed, purely morphological criteria seem to be insufficient for distinguishing lung cancer from benign nodules at early stages with sufficient confidence, therefore false positives undergoing surgical resection frequently occur. A molecular approach to the diagnosis of lung cancer through the analysis of exhaled breath could greatly improve the specificity of imaging procedures. A biomarker-driven approach to signs or symptoms possibly due to lung cancer would represent a complementary tool aimed at ruling out (with known error probability) rather than diagnosing lung cancer. Volatile and nonvolatile components of the breath are being studied as biomarkers of lung cancer. Breath testing is noninvasive and potentially inexpensive. There is promise that an accurate lung cancer breath biomarker, capable of being applied clinically, will be developed in the near future. In this article, we summarize some of the rationale for breath biomarker development, review the published literature in this field and provide thoughts regarding future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Quantitative analysis of ammonia on the breath of patients in end-stage renal failure
Davies, S., Spanel, P., & Smith, D. (1997) · Kidney International · doi:10.1038/ki.1997.324 · Cited by 406
Cited by
Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways
Hakim, M., Broza, Y. Y., Barash, O., Peled, N., Phillips, M., Amann, A., & Haick, H. (2012) · Chemical Reviews · doi:10.1021/cr300174a · Cited by 953
Self-citationOptical sensor arrays for chemical sensing: the optoelectronic nose
Askim, J. R., Mahmoudi, M., & Suslick, K. S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60179j · Cited by 886
Amann, A., Costello, B. D. L., Miekisch, W., Schubert, J., Buszewski, B., Pleil, J., Ratcliffe, N., & Risby, T. (2014) · Journal of Breath Research · doi:10.1088/1752-7155/8/3/034001 · Cited by 804
Self-citationNakhleh, M. K., Amal, H., Jeries, R., Broza, Y. Y., Aboud, M., Gharra, A., Ivgi, H., Khatib, S., Badarneh, S., Har-Shai, L., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b04930 · Cited by 510
Breath analysis by nanostructured metal oxides as chemo-resistive gas sensors
Righettoni, M., Amann, A., & Pratsinis, S. E. (2015) · Materials Today · doi:10.1016/j.mattod.2014.08.017 · Cited by 487
Self-citation
Metadata
- Authors
- Amann, A., Corradi, M., Mazzone, P., & Mutti, A.
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2011-03
- Volume
- 11
- Issue
- 2
- Pages
- 207-217
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2004144190
- Cited by
- 163
- References
- 2
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung cancer biomarkers in exhaled breath. https://app.cochat.ai/papers/10.1586/erm.10.112
- The paper
- Amann, A., Corradi, M., Mazzone, P., & Mutti, A. (2011). Lung cancer biomarkers in exhaled breath. Expert Review of Molecular Diagnostics. https://doi.org/10.1586/erm.10.112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.